NCT00004262View on ClinicalTrials.gov

Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 1999

Primary Completion Date

May 31, 2005

Conditions

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma

Interventions

PROCEDURE

conventional surgery

RADIATION

3-dimensional conformal radiation therapy

RADIATION

stereotactic radiosurgery

DRUG

motexafin gadolinium

Given IV

PROCEDURE

magnetic resonance imaging

Undergo MRI with both the clinical 1.5 Tesla and research 8 Tesla magnets

PROCEDURE

spectroscopy

Undergo plasma-atomic emission spectroscopy (DCP-AES)

Trial Locations (1)

43210

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00004262 - Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme | Biotech Hunter | Biotech Hunter